RESULTS IN PN YOU CAN SEE AND FEEL–THAT’S A WIN FOR SKIN

Backed by science, DUPIXENT is the first FDA-approved
treatment for prurigo nodularis (PN).

In two clinical studies with 311 adults with PN. SKIN CLEAR OR ALMOST CLEAR OF PN BUMPS AT 24 WEEKS

DUPIXENT
VS
Not on DUPIXENT
In two clinical studies with 311 adults with PN. NOTICEABLY LESS ITCH
AT 24 WEEKS

DUPIXENT
VS
Not on DUPIXENT
In one study Less itch
In As Little As 12 Weeks

DUPIXENT
VS
Not on DUPIXENT

The most common side effects in patients with prurigo nodularis include:

  • Eye and eyelid inflammation, including
    redness, swelling, and itching, sometimes with blurred vision
  • Herpes virus infections
  • Common cold symptoms (nasopharyngitis)
  • Dizziness
  • Muscle pain
  • Diarrhea

View Before and After Results With DUPIXENT

Use the slider to view these before and after results with 32 weeks of treatment with DUPIXENT.

Real patient shown. Additional factors (including possible use of other treatments) may have
impacted results. Individual results may vary.


Click and drag
to see results
Click and drag
to see results

Prior to starting DUPIXENT,
I was uncomfortable about
the many nodules on my
arms and legs.

—Brooke, actual DUPIXENT patient

Take Back Control By Talking to
Your Doctor

You have a lot of questions and deserve to get the right answers. Our personalized discussion guide lets you document your symptoms and severity so you can take them straight to your doctor.

FIND A SPECIALIST
WHO TREATS PN

Use this Healthgrades™ tool to easily find nearby specialists with experience in treating adults suffering from prurigo nodularis.

Sanofi US and Regeneron do not endorse or recommend any
particular physician, and search results do not include a
comprehensive list of doctors in your area.